Wellspring — the health of private biotech

Like

tree

Source: Thinkstock

For nonsubscribers, we’ve made our annual feature on the health of the private biotech space freely available.  Many of the data are supplied by Dow Jones VentureSource, tailored to our requests and definitions of biotech, and highlight what some already know: venture capital funding for early stage innnovative companies continues to dwindle. The article also investigates start-up activity from universities, exits and more.  Go here for the PDF, and here for HTML version.

This follows up on last year’s article, which is also free and can be found here.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Biotechnology
Life Sciences > Biological Sciences > Biotechnology